CoreFirst Bank & Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
CoreFirst Bank & Trust's NVS Position: Q1 2026 in Review
CoreFirst Bank & Trust increased its Novartis (NVS) stake by 1.2% in Q1 2026, buying an estimated $6.13K and bringing the position to 3,490 shares worth $533K. The position accounts for 0.28% of the portfolio, ranked #67.
CoreFirst Bank & Trust first reported a position in NVS in Q4 2020 and has held it in 22 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- CoreFirst Bank & Trust held 3,490 shares of Novartis worth $533K as of Q1 2026.
- CoreFirst Bank & Trust bought 40 Novartis shares in Q1 2026, an estimated $6.13K.
- Novartis made up 0.28% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #67 holding.
- CoreFirst Bank & Trust first reported a position in Novartis in Q4 2020 and has held it in 22 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.